Viewing Study NCT00120835


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-25 @ 7:49 PM
Study NCT ID: NCT00120835
Status: COMPLETED
Last Update Posted: 2010-06-10
First Post: 2005-07-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module